Newspaper Publication of Audited Financial Results of the Company for the quarter and year ended March 31, 2026
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Emcure Pharmaceuticals has published its Q4 and FY 2026 audited financial results in newspapers 'Financial Express' and 'Loksatta' on May 6, 2026. This is a regulatory compliance filing under SEBI Listing Regulations (Regulation 47), which requires listed companies to publicly disseminate their financial results through newspapers. The company has notified both NSE and BSE about this publication. The actual financial numbers and performance details are contained in the newspaper extracts rather than this cover letter. The results are also available on the company's website.
This filing confirms regulatory compliance. Actual financial performance data for Q4 and FY 2026 needs to be reviewed from the newspaper publications or company website to assess impact on the stock.